Introduction of In Vivo Survival AssessmentB cell-based immunotherapy has shown great potential in cancer treatment applications. B cells in the mature tertiary lymphoid structures (TLS) could not only secrete antibodies but also mediate tumor apoptosis, phagocytosis, and antibody-dependent cellular cytotoxicity (as shown in Fig.1), which results in improving patient overall survival.
Antibody Regimens for Leukemia
Leukemia is a generic term for cancers of the bone marrow and lymphatic system. Leukemia is the most common disease in adults over 55 years old, while it is also the most often cancer in children under 15 years old. There are four main types of leukemia, each named for the rate at which the disease progresses and worsens as well as the blood cell type affected.
Antibodies, the extraordinary proteins that serve as the frontline troops of the human immune system, have recently gained attention for their ability to combat tiny compounds known as haptens. Because of their small size, these elusive targets present particular difficulty for the immune system to identify as foreign invaders. However, researchers' inventiveness has resulted in the creation of...
The clinical efficacy of solid tumor CAR-T therapies hinges on overcoming metabolic barriers within the tumor microenvironment. This article explores how tracking CD8+ T cell metabolic reprogramming, glucose competitive kinetics, and cytokine secretion feedback can guide the precise engineering of persistence-enhanced cell therapies.
While Chimeric Antigen Receptor (CAR) T-cell...
The cell therapy industry is moving toward more precise, scalable, and controllable immunotherapies. As researchers address challenges in CIK cell potency, consistency, and manufacturing complexity, Creative Biolabs provides advanced CIK development solutions supporting the future of cancer immunotherapy innovation.
The global cell therapy industry is entering a new stage of...
Advanced in vitro epilepsy and lesion‑induced models offer scalable, human‑relevant tools for studying neural excitability, injury responses, and CNS disease mechanisms.
Understanding neurological disorders requires model systems that can capture the complexity of human neural circuits while remaining experimentally accessible. Recent progress in in‑vitro epilepsy models...
Traditional neuroscience models often struggle to replicate human brain complexity, limiting predictive accuracy and creating challenges for drug discovery and neurological disease research. Advanced 3D neural spheroids and brain-on-a-chip technologies are emerging as valuable platforms to improve biological relevance, accelerate innovation, and support next-generation neuroscience studies....
SkillClick
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek